More SEC Filings
View Older Stories View Newer Stories-
Form 4 BranchOut Food Inc. For: Jan 28 Filed by: Kaufman Daniel Louis
-
Form 3 Newbridge Acquisition For: Jan 29 Filed by: Li Jining
-
Form 3 Newbridge Acquisition For: Jan 29 Filed by: Lee Angela
-
Form SCHEDULE 13G/A Personalis, Inc. Filed by: HIRSCHMAN ORIN
-
Form 4 Definium Therapeutics, For: Jan 29 Filed by: Adsett Roger
-
Form 4 Natera, Inc. For: Jan 27 Filed by: Sheena Jonathan
-
Form 4 Natera, Inc. For: Jan 27 Filed by: RABINOWITZ DANIEL
-
Form 4 Natera, Inc. For: Jan 27 Filed by: Fesko John
-
Form 4 Natera, Inc. For: Jan 27 Filed by: Moshkevich Solomon
-
Form SCHEDULE 13G/A Ideal Power Inc. Filed by: HIRSCHMAN ORIN
-
Form 3 Definium Therapeutics, For: Jan 29 Filed by: Adsett Roger
-
Form SCHEDULE 13G/A BiomX Inc. Filed by: HIRSCHMAN ORIN
-
Form SCHEDULE 13G/A Dror Ortho-Design, Inc. Filed by: HIRSCHMAN ORIN
-
Form 4 POWER INTEGRATIONS INC For: Jan 27 Filed by: Jain Gagan
-
Form 4 POWER INTEGRATIONS INC For: Jan 27 Filed by: Gupta Sunil
-
Form SCHEDULE 13G/A KIORA PHARMACEUTICALS Filed by: HIRSCHMAN ORIN
-
Form 4 COMPASS MINERALS INTERNA For: Dec 18 Filed by: Safran David
-
Form 3 COMPASS MINERALS INTERNA For: Dec 18 Filed by: Safran David
-
Form 3 PMGC Holdings Inc. For: Mar 06 Filed by: Kovalyov George
-
Form 4 Urban Edge Properties For: Jan 27 Filed by: Drazin Andrea Rosenthal
-
Form 4 Urban Edge Properties For: Jan 27 Filed by: Olson Jeffrey S
-
Form 4 Urban Edge Properties For: Jan 27 Filed by: Mooallem Jeffrey
-
Form 4 Urban Edge Properties For: Jan 27 Filed by: Ohlberg Heather
-
Form 4 Urban Edge Properties For: Jan 27 Filed by: Langer Mark
-
Form S-1MEF M Evo Global Acquisition
-
Form 4 Sarepta Therapeutics, For: Jan 29 Filed by: Nicaise Claude
-
Form 4 Sarepta Therapeutics, For: Jan 27 Filed by: BEHRENS M KATHLEEN
-
Form 4 TKO Group Holdings, Inc. For: Jan 27 Filed by: KRAUSS SETH D
-
Form 4 TKO Group Holdings, Inc. For: Jan 27 Filed by: Kapral Shane
-
Form 4 VivoSim Labs, INC. For: Jan 27 Filed by: Cohen Douglas Jay
-
Form SCHEDULE 13G/A Ventyx Biosciences, Inc. Filed by: Affinity Asset Advisors, LLC
-
Form SCHEDULE 13G/A Verrica Pharmaceuticals Filed by: Affinity Asset Advisors, LLC
-
Form 4 VivoSim Labs, INC. For: Jan 27 Filed by: Murphy Keith
-
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: Affinity Asset Advisors, LLC
-
Form SCHEDULE 13G/A SUTRO BIOPHARMA, INC. Filed by: Affinity Asset Advisors, LLC
-
Form SCHEDULE 13G/A Forte Biosciences, Inc. Filed by: Affinity Asset Advisors, LLC
-
Form SCHEDULE 13G/A Ovid Therapeutics Inc. Filed by: Affinity Asset Advisors, LLC
-
Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: Affinity Asset Advisors, LLC
-
Form 4 VivoSim Labs, INC. For: Jan 27 Filed by: Milhous Alison Tjosvold
-
Form 4 VivoSim Labs, INC. For: Jan 27 Filed by: Gobel David
-
Form 4 USA Rare Earth, Inc. For: Jan 29 Filed by: Trabuco Carolyn
-
Form 4 VivoSim Labs, INC. For: Jan 27 Filed by: STERN ADAM K
-
Form SCHEDULE 13D/A NovaBay Pharmaceuticals, Filed by: Lazar David E.
-
Form 4 Ainos, Inc. For: Jan 28 Filed by: Taiwan Carbon Nano Technology Corp
-
Form 4 NovaBay Pharmaceuticals, For: Oct 21 Filed by: Lazar David E.
-
Form 144 GeneDx Holdings Corp. Filed by: Feeley Kevin
-
Form 144 GeneDx Holdings Corp. Filed by: Stueland Katherine
-
Form 4 System1, Inc. For: Jan 28 Filed by: Kidambi Tridivesh
-
Form 4 System1, Inc. For: Jan 28 Filed by: Sestanovich Elizabeth
-
Form 4 System1, Inc. For: Jan 28 Filed by: Coppola Brian
